Sarfaraz, M. et al. 2020. Formulation and Evaluation of Galantamine Hydrobromide Proniosome Gel for Alzheimer’s disease. Journal of Drug Delivery and Therapeutics. 10, 2-s (Apr. 2020), 68–74. DOI:https://doi.org/10.22270/jddt.v10i2-s.4027.